Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Anatomy Item Literature (2419) Expression Attributions Wiki
XB-ANAT-28

Papers associated with epidermis (and abcc8)

Limit to papers also referencing gene:
Show all epidermis papers
???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest Sort Oldest To Newest

Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2/SUR1 but not Kir6.2/SUR2A KATP channels: a mechanistic study., Proks P., J Gen Physiol. November 1, 2014; 144 (5): 469-86.                  


Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes., Proks P., Diabetes. November 1, 2013; 62 (11): 3909-19.              


Neurally Derived Tissues in Xenopus laevis Embryos Exhibit a Consistent Bioelectrical Left-Right Asymmetry., Pai VP., Stem Cells Int. January 1, 2012; 2012 353491.          


Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes., Männikkö R., Diabetes. June 1, 2011; 60 (6): 1813-22.              


Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies., Pörksen S., BMC Endocr Disord. September 23, 2010; 10 16.      


Relapsing diabetes can result from moderately activating mutations in KCNJ11., Gloyn AL., Hum Mol Genet. April 1, 2005; 14 (7): 925-34.


Inhibition of recombinant K(ATP) channels by the antidiabetic agents midaglizole, LY397364 and LY389382., Proks P., Eur J Pharmacol. September 27, 2002; 452 (1): 11-9.


The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener., Dabrowski M., Diabetes. June 1, 2002; 51 (6): 1896-906.


Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels., Song DK., Br J Pharmacol. May 1, 2001; 133 (1): 193-9.


Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel., Reimann F., Br J Pharmacol. April 1, 2001; 132 (7): 1542-8.


The antimalarial agent mefloquine inhibits ATP-sensitive K-channels., Gribble FM., Br J Pharmacol. October 1, 2000; 131 (4): 756-60.


Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone., McKay NG., Br J Pharmacol. June 1, 2000; 130 (4): 857-66.


Expression of Xenopus snail in mesoderm and prospective neural fold ectoderm., Essex LJ., Dev Dyn. October 1, 1993; 198 (2): 108-22.              

???pagination.result.page??? 1